Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T27719 |
KD-026
SLx 4090,SLx4090,KD026,SLx-4090 |
CETP | Metabolism |
KD-026 (SLx 4090) 是具有口服活性的、肠细胞特异性的微粒体甘油三酯转移蛋白 (MTP)抑制剂,IC50为 8.0 nM。KD-026 (SLx 4090) 在糖尿病2型中有研究的价值。 | |||
T68375 |
KD026-metabolite
|
||
KD026-metabolite, is a metabolite of KD-026. KD026, also known as SLx-4090, is a microsomal triglyceride transfer protein (MTTP) inhibitor potentially for the treatment of type 2 diabetes. |